Dorsey & Whitney Trust CO LLC Purchases New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Dorsey & Whitney Trust CO LLC purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, Holdings Channel reports. The firm purchased 2,200 shares of the exchange traded fund’s stock, valued at approximately $204,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. ICA Group Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth $27,000. Scarborough Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $32,000. BOCHK Asset Management Ltd purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $36,000. ORG Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter worth about $40,000. Finally, Vima LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $45,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $99.06 on Friday. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The firm’s 50-day moving average price is $98.29 and its 200-day moving average price is $93.94. The company has a market capitalization of $7.55 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.